- Investing Ideas
- Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
Viyash Scientific
Market Cap: ₹116.3b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
New
512529
₹255.60
7D
-7.8%
1Y
45.7%
Strides Pharma Science
Market Cap: ₹91.2b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹967.80
7D
-3.6%
1Y
8.1%